Subclinical atherosclerosis: evolving role of carotid intima-media thickness.
Cardiovascular risk factors have utility in risk prediction but have limitations in predicting individual risk. Identifying an individual's risk remains a challenge. Emerging technologies such as carotid artery ultrasonography and measures of carotid intima-media thickness (CIMT) may be useful in identifying the susceptible patient who may benefit from more aggressive preventive therapy. This screening test is noninvasive, reproducible, inexpensive, and radiation-free. Recent data have improved our understanding of the application of CIMT as a screening tool for cardiovascular disease. CIMT measurement may place an individual into a higher- or lower-risk category, allowing for appropriate institution of preventive strategies.
Mookadam
Farouk
F
Department of Cardiovascular Diseases, Mayo Clinic Scottsdale, Scottsdale, AZ, USA. mookadam.farouk@mayo.edu
Moustafa
Sherif E
SE
Lester
Steven J
SJ
Warsame
Tahlil
T
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001384:Azetidines / Q000627:therapeutic use; D002339:Carotid Arteries / Q000473:pathology*; D002340:Carotid Artery Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D018450:Disease Progression; D000069438:Ezetimibe; D006801:Humans; D011379:Prognosis; D012307:Risk Factors; D017539:Tunica Intima / Q000473:pathology*; D017540:Tunica Media / Q000473:pathology*
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D001384:Azetidines; D000069438:Ezetimibe